ACTU vs GILD: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics, Inc. Common stock and Gilead Sciences Inc in 2026
ACTU
Actuate Therapeutics, Inc. Common stock
—
GILD
Gilead Sciences Inc
$132.16
Key Metrics Comparison
| Metric | ACTU | GILD | Winner |
|---|---|---|---|
| Market Cap | $49.05M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ACTU
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or GILD a better investment?
Comparing ACTU and GILD: Actuate Therapeutics, Inc. Common stock has a market cap of $49.05M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and GILD?
ACTU (Actuate Therapeutics, Inc. Common stock) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or GILD?
Both ACTU and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ACTU or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ACTU or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $49.05M for ACTU.
Should I buy ACTU or GILD in 2026?
Both ACTU and GILD have investment merit. ACTU trades at $N/A while GILD trades at $132.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and GILD stock?
Key differences: Market Cap ($49.05M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ACTU or GILD in 2026?
The choice between ACTU and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ACTU and GILD?
ACTU (Actuate Therapeutics, Inc. Common stock) has a market cap of $49.05M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.